- Will your smartphone tell someone if you’ve been to an abortion clinic?
- 1 avocado a week reduces the risk of cardiovascular disease by 22%
- The COVID-19 epidemic comes back again in Japan
- The most reliable study: 1 in 8 COVID-19 patients will have long-term sequelae
- Noncoding DNA may lead to the development of cancer
- Scientists grow embryos without Sperm Eggs and Uterus
All cancers can be simply divided into two categories, according to whether they express YAP protein
- A highly infectious disease that has been extinct for more than 40 years has appeared in New York
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Omicron new variant BA.2.75 has stronger infectivity than BA.4 and BA.5?
- Taiwan death from COVID-19 vaccination exceeds death from COVID-19
- The world top 5 best-selling drugs in 2020
Cancer Cell: All cancers can be simply divided into two categories, according to whether they express YAP protein.
YAP protein (Yes-Associated Protein)is the core effector of the Hippo signaling pathway.
It is a multifunctional intracellular connexin and transcription co-activator, which plays a role in signal transduction and gene transcription regulation in normal cells.
Many studies have shown that YAP is involved in tumorigenesis and development, and plays the role of oncogene in the body. Increased expression and activity of YAP can promote malignant transformation of cells.
In July 2021, researchers from Toronto Mount Sinai Hospital and the University of Toronto published a research paper titled Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity in Cancer Cell .
The study shows that all cancers can be divided into two categories based on whether they express YAP protein.
This discovery provides a new strategy for the treatment of the most aggressive and incurable types of cancer.
As an important regulator and effector of the Hippo signaling pathway, YAP plays an important role in the formation of malignant tumors.
YAP exists in all cancers, regardless of whether its expression is turned on or off. This is related to its drug sensitivity or drug resistance.
When culturing cancer cells in the laboratory, the cancer cells are either suspended or adherent, and YAP is its main regulator.
All suspended cancer cells are YAP expression turned off ( YAPoff ), and all adherent Cancer cells are all turned on by YAP expression ( YAPon ).
This change in cell adhesion behavior is related to drug resistance and invasiveness, which indicates that YAP is the key to this drug resistance change and malignant transformation.
In cancer cells, the closing or opening of YAP has the opposite effect of promoting or suppressing cancer.
For YAPon cancer, the presence of YAP is required to grow and survive, while for YAPoff cancer, the presence of YAP can inhibit the growth of cancer cells.
The research team also found that YAPoff cancers are usually highly lethal , such as retinoblastoma, small cell lung cancer, and neuroendocrine prostate cancer.
Some cancers such as prostate cancer and lung cancer can also transition from YAPon state to YAPoff state to resist treatment .
Therefore, the method of preventing this YAP state transition can be an effective method of preventing drug resistance.
In general, this study shows that all cancers can be divided into two categories based on the presence or absence of YAP protein- YAPon cancer and YAPoff cancer .
This simple binary classification may have a profound impact on cancer treatment, and can be used to infer the vulnerability of cancer, develop new therapies, and improve the effectiveness of cancer treatment.
Cancer Cell: All cancers can be simply divided into two categories
(source:internet, reference only)